Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant APP (Donanemab Biosimilar) antibody

This anti-APP (Donanemab Biosimilar) antibody is a Humanized Chimeric antibody detecting APP (Donanemab Biosimilar) in not_set. Suitable for Human.
Catalog No. ABIN7597634
-15% Promotion 2026
$340.97
$401.14
save $60.17 (-15 %)
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to: United States
Delivery in 12 to 14 Business Days

Quick Overview for Recombinant APP (Donanemab Biosimilar) antibody (ABIN7597634)

Target

APP (Donanemab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 1
Humanized

Clonality

  • 1
Chimeric

Conjugate

  • 1
This APP (Donanemab Biosimilar) antibody is un-conjugated

Application

Please inquire

Grade

Research Grade
  • Expression System

    Mammalian cells

    Purpose

    Research Grade Donanemab Biosimilar Antibody

    Specificity

    AICD-57, A4, Beta-CTF, Protease nexin-II, Gamma-CTF(50), ABPP, S-APP-beta, APP, Abeta40, Abeta42, AID(59), Amyloid intracellular domain 59, AID(57), S-APP-alpha, Gamma-CTF(59), Beta-secretase C-terminal fragment, Amyloid-beta precursor protein, Amyloid precursor protein, Beta-APP42, PreA4, Alzheimer disease amyloid protein, APPI, PN-II, AICD-59, Alpha-secretase C-terminal fragment, Amyloid-beta A4 protein, Amyloid intracellular domain 57, CVAP, Amyloid intracellular domain 50, Beta-APP40, AD1, Cerebral vascular amyloid peptide, AID(50), Alpha-CTF, Gamma-CTF(57), AICD-50

    Purification

    Protein A or G purified from cell culture supernatant.

    Purity

    >95 % by SDS-PAGE.

    Isotype

    IgG1 kappa
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1.42 mg/mL

    Buffer

    0.01M PBS, pH 7.4.

    Storage

    4 °C,-20 °C,-80 °C

    Storage Comment

    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

    Expiry Date

    12 months
  • Target

    APP (Donanemab Biosimilar)

    Alternative Name

    Donanemab Biosimilar

    Target Type

    Biosimilar

    Background

    AICD-57, A4, Beta-CTF, Protease nexin-II, Gamma-CTF(50), ABPP, S-APP-beta, APP, Abeta40, Abeta42, AID(59), Amyloid intracellular domain 59, AID(57), S-APP-alpha, Gamma-CTF(59), Beta-secretase C-terminal fragment, Amyloid-beta precursor protein, Amyloid precursor protein, Beta-APP42, PreA4, Alzheimer disease amyloid protein, APPI, PN-II, AICD-59, Alpha-secretase C-terminal fragment, Amyloid-beta A4 protein, Amyloid intracellular domain 57, CVAP, Amyloid intracellular domain 50, Beta-APP40, AD1, Cerebral vascular amyloid peptide, AID(50), Alpha-CTF, Gamma-CTF(57), AICD-50

    UniProt

    P05067

    CAS-No

    1931944-80-7
You are here:
Chat with us!